National Institutes of Health logo
NIH Exploratory/Developmental Cooperative Agreement Phase I (UH2)

Assay Validation of High Quality Markers for Clinical Studies in Cancer

Funds analytically and clinically validating a cancer biomarker and its assay for detection, diagnosis, prognosis or treatment response.

Between cyclesNational Institutes of HealthUnited States

A biomarker that looks promising in a lab is not the same as an assay a clinical laboratory can actually run and trust.

This notice funds two routes to closing that gap. A biphasic UH2/UH3 award, running up to five years, takes an assay through analytical validation first โ€” up to two years, in the UH2 phase โ€” and then clinical validation for up to three years in the UH3 phase, using well-annotateโ€ฆ

Analytical and clinical validation of molecular, cellular or imaging cancer biomarkers and their assays for detection, diagnosis, prognosis, monitoring, treatment-response prediction, prevention, control, or pharmacodynamic and toxicity measurement, through a biphasic UH2/UH3 award or a monophasic standalone UH3 award for an already analytically validated assay.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.8 Feb 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
National Institutes of Health logo
Open

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds a pilot trial of a behavioural sleep intervention for adolescents and young adults who have a mental health disorder or are at risk of one.

Oct'26
National Institutes of Health logo
Open

GREGoRi Data Coordination and Outreach Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.

BiotechAI
$1.3MOct'26
National Institutes of Health logo
Open

GREGoRi Innovation Projects

NIH ยท United States

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

BiotechAI
$3 โ€“ $500KOct'26
National Institutes of Health logo
Open

GREGoRi Technology Integration Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.

BiotechAI
$2.3MOct'26
National Institutes of Health logo
Open

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.

Medtech
Nov'26
National Institutes of Health logo
Open

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.

MedtechBiotech
Nov'26